Second, CML treatment resulted in highernormalized expression (ΔCt) of the NF-κB gene in DN(P=6.0×10-5) and T2DM (P=1.5×10-5), but not in healthyvolunteers (P=0.08) (Wilcoxon signed-rank test). This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.